RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S.

₺1.98As of Sun 8 Nov 2026, 12:00 UTC
BIST:RTALBHealthcare
Country Turkey
PE (Fwd) •••
TSR 10Y CAGR 26.98%
Div yield —
ROE (15.16%)
Biotechnology
Beta (5Y) 0.47
PE TTM —
TSR TTM (54.69%)
Mkt cap ₺990.0M
ROIC (0.64%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₺2.09
5.54%
(80.09%)
Hold 9|2|6|0|6
4Q25
1Q26
2Q26
3Q26
Earnings per share₺
0.03
0.03
0.03
0.04
13.69%
17.12%
2.07%
12.69%
Revenue₺M
74.56
75.93
75.44
76.13
17.47%
14.05%
7.27%
4.27%
Peers (US$19.75M)
Cap (US$)
PE
386.0M
22.71x
321.2M
—
Capital
TTM
5Y
10Y
Leveragex
0.442
0.027
0.028
EBIT/Intx
0.579
1.051
0.882
Own earn%
(17.08)
91.34
107.33
Sh yield%
21.63
42.70
43.15
Owners
Insiders/Inst%
12.54
40.22
Short interest%
3.15
SBC / revenue%
5.20
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
4
Op margin range%
17–22
$1 testx
0.1
Incr. ROIC%
7